(Updated - February 10, 2025 7:28 AM EST)

Guggenheim analyst Yatin Suneja lowered the price target on Immunovant (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE